26th Nov 2021 12:59
Silence Therapeutics PLC - novel RNA therapeutics developer with offices in London and Berlin - Says last day of trading of shares on AIM will be Monday, and delisting to be effective from Tuesday. Will retain listing of American Depositary Shares on the Nasdaq Global Market.
Current stock price: 533.00 pence, down 3.1% on Friday
Year-to-date change: up 3.7%
By Lucy Heming;Â [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.